Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Kernal Biologics Inc. is a biotechnology company pioneering mRNA 2.0 technology to develop advanced cancer therapeutics. Their approach focuses on enabling specific cells to produce their own medicines, aiming to overcome the limitations of conventional RNA therapies and enhance treatment efficacy. The company leverages existing mRNA manufacturing infrastructure for scalable production of its drug candidates, with a mission to improve patient outcomes in oncology.
Primary hub for research and development, laboratory operations, corporate administration, and strategic planning.
Features state-of-the-art laboratory spaces specifically designed for mRNA research, development, and analytics, occupying 13,000 square feet in a modern life sciences building.
The Cambridge HQ fosters a dynamic, science-driven work culture characterized by innovation, collaboration among multidisciplinary teams, and a shared commitment to advancing cancer treatments. Employees often experience a fast-paced environment typical of biotech startups, with opportunities for significant impact.
The Cambridge headquarters is pivotal, positioning Kernal within one of the world's leading biotech ecosystems (near Kendall Square). This provides critical access to top-tier talent, academic collaborations, venture capital, and a network of peer companies, accelerating its R&D and business development efforts.
Kernal Biologics is primarily focused on research and development within the United States, with its operations centered at its Cambridge, MA headquarters. While its therapeutic ambitions are global, its current physical presence and direct operations are concentrated in the US biotech hub. Future global expansion may occur as drug candidates progress through clinical trials and towards commercialization.
200 Sydney Street
Cambridge
MA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Kernal Biologics' leadership includes:
Kernal Biologics has been backed by several prominent investors over the years, including:
Kernal Biologics strengthened its executive team with the appointment of a Chief Medical Officer in early 2024 to spearhead clinical development. No other major executive changes have been publicly announced in the last 12 months.
Discover the tools Kernal Biologics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Kernal Biologics Inc. likely utilizes common corporate email formats. Based on publicly available information for executives, a primary format appears to be the first initial followed by the last name.
[first_initial][last]@kernalbio.com
Format
yerkul@kernalbio.com
Example
75%
Success rate
kernalbio.com (Press Release) • January 8, 2024
Kernal Biologics announced the appointment of Marcello Cherchi, M.D., Ph.D., as its Chief Medical Officer. Dr. Cherchi brings extensive experience in oncology and clinical development to drive Kernal's therapeutic programs forward....more
Business Wire / kernalbio.com (Press Release) • May 4, 2023
Kernal Biologics secured $25 million in Series A financing led by General Catalyst, with participation from new and existing investors. The funds are designated to advance its pipeline of mRNA 2.0 therapeutics for cancer treatment and to expand its team and platform capabilities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Kernal Biologics, are just a search away.